ALK and anaplastic large cell lymphoma: Thus, miRNA do not only influence the cellular phenotype and pathogenesis of ALK(+) ALCL but they are also emerging as tissue-specific biomarkers with potential clinical applications for both identifying cancer subtypes and developing new therapies [17].